Humanity

The important factor for our success is the right team and the right spirit within. By having a personal relationship and focus on authentic code of conduct we aim to promote the ever-growing capabilities of each and every INCYTOИAUT.

Openness

We embrace change and are always forward-looking. We are courageous on our journey to discover whatever is out there. We respect diversity, all kind of opinions and backgrounds and are open for the many sassy solutions to real world challenges we are facing as a team.

Focus

By all the playing and experimental fun, we focus on the results and stay professional when we should. We keep it easy and have a high sense of quality in mind for all our doings. Thereby we love to experiment and get initial results fast.

Commitment

We are passionate about what we do, because we care about the outcome. The extra mile can be a delight for us, if the challenge was solving the unthinkable.

WHO WE ARE

Although INCYTON® is quite young, it has already a considerable amount of experience in the field of technical development of analytical processes and devices for research purposes. Our network in the community is broadly based and we are still reaching out to get in contact with new connections and use cases every day. We trust on grown collaborations, a high-quality supplier network and the never-ending ideas of scientists all over the world.

VALUES

We rely on the following basic values as the basis of all our actions:

Commitment + Focus + Humanity + Openness

WHAT WE ASPIRE TO

VISION

INCYTON® constantly strives for new horizons in the field of cell-based analysis. Our goal is to continuously increase the achievable information content in each experiment, performing cell-based high-throughput analyses.
By promoting the paradigm shift from endpoint to kinetic measurement, we enable scientists to gain faster and more accurate insights from in vitro experiments, especially in basic and pharmaceutical research.

MISSION

Customers and employees are our top priority. By working together, and through the development of analytical platforms and suitable measuring systems, we aim for a comprehensive and complete understanding of global cellular reactions. We engage in future-oriented research through our entirely  “Made in Germany”  solutions.
Our intent is to improve the prediction of the effects of active substances, drugs and drug candidates already in preclinical phase as well as in regulatory validation studies. 

OUR TEAM

We as INCYTON® find ourselves at home in a universe where biology and technology are combined in one sphere. We see ourselves a little bit as time traveler towards future, as pioneer in our technology space and explorer in the cell. Therefore, we love the description of being an INCYTONAUT.

DR. MARTIN STREHLE
Chief Executive Officer
Masters in Biochemistry, PhD in Biochemistry and Molecular Biology, MBA
Dr. Peter Wolf
Chief Scientific Officer
Masters in Biology (Dipl.-Biol.), PhD in Life Sciences
Matthias Moll
Chief Operating Officer / Head of Product Development
Masters in Construction Engineering (Dipl.-Ing.)
Marton Nagy
Technical Sales Account Executive
Masters in Biotechnology and Bioengineering
Ozan Günaydin
Head of Electrical Engineering
B.Sc. in Electrical Engineering and M.Sc. in Biomedical Engineering
Christina Heichler
Cell-based Assay Scientist
Bachelor in Biotechnology and Masters in Molecular Biotechnology.
PhD candidate in the field of cancer biology

2007

OUR HISTORY

INCYTON® is a privately financed spinoff company of HP Medizintechnik GmbH, a manufacturer of laboratory devices and steam sterilizers. In close collaboration with the chair for biomedical electronics under leadership of Prof. Dr. B. Wolf (TU München) HP Medizintechnik GmbH has conducted several research projects to dive into the idea of enabling the scientific community with continuously observation and simultaneously measuring of key parameters of cellular changes. Back in 2007 our founder Dr.-Ing. H. Herz and Prof. Dr. B. Wolf initiated the basic outlines of our understanding how cells should be investigated, creating the device IMR (Intelligent Microplate Reader), the first version of the INCYTON® platforms. Over ten years of hard development and proof-of-concept work later, we can now base our knowledge on several high impact bachelor, master and PhD theses as well as three successful publicly funded research projects.